Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
2020
(2)
2016
(2)
2015
(3)
Decision
Transfer
(7)
Complainant
Boehringer Ingelheim Pharma GmbH & Co. KG
(4)
Boehringer Ingelheim Pharma GMBH & CO. KG
(2)
Boehringer Ingelheim Pharma GmbH & Co. KG.
(1)
Respondent
Mojtaba Alimardani
(2)
Zhao Ke
(1)
Whoisguard Protected, Whoisguard, Inc. / ESQUIRE 5, J Gates
(1)
Whoisguard Protected / Whoisguard, Inc., J Gates, My Domain Estates
(1)
Privacy Protect, LLC (PrivacyProtect.org) / Yabani Eze, Sugarcane Internet Nigeria Limited
(1)
JH Kang
(1)
Panelist
Roberto Bianchi
(1)
Nasser A. Khasawneh
(1)
Matthew S. Harris
(1)
Ingrīda Kariņa-Bērziņa
(1)
Gabriela Kennedy
(1)
Debra J. Stanek
(1)
Albert Agustinoy Guilayn
(1)
Complainant Country
Germany
(7)
Complainant Representative
Nameshield
(7)
Respondent Country
Panama
(2)
Iran
(2)
Niger
(1)
Chile
(1)
Respondent Reply
Yes
(7)
RDNH Status
No
(7)
Case Language
English
(6)
Spanish
(1)
Case Particular
DIR
(2)
DCO
(2)
D
(2)
DES
(1)
Number Of Domains
1
(7)
Domain Extension
ir
(2)
com
(2)
co
(2)
es
(1)
Domain Extension Type
ccTLD
(5)
gTLD
(2)
Domain Length
8
(1)
9
(1)
10
(1)
12
(1)
20
(1)
24
(1)
29
(1)
Includes Hyphen
Yes
(1)
No
(6)
Includes Number
No
(7)
Includes Letter
Yes
(7)
Domain Registrar
eNom, Inc.
(2)
IRNIC
(2)
Red.es
(1)
GoDaddy.com, LLC
(1)
7
cases found.
Complainant: Boehringer Ingelheim Pharma GmbH & Co. KG
Complainant Representative: Nameshield
Decision: Transfer
Respondent Reply: Yes
Reset Search
boehringeringelheimpetrebates.co
Transfer
WIPO DCO2020-0041
(Decision Date: Sept. 15, 2020)
tradjenta.co
Transfer
WIPO DCO2020-0001
(Decision Date: March 5, 2020)
dulcolax.es
Transfer
WIPO DES2016-0035
(Decision Date: Dec. 20, 2016)
boehringeringelheimsucks.com
Transfer
WIPO D2015-1542
(Decision Date: Oct. 21, 2015)
spirivasucks.com
Transfer
WIPO D2015-0978
(Decision Date: Aug. 17, 2015)
boehringer.ir
Transfer
WIPO DIR2015-0017
(Decision Date: Jan. 6, 2016)
boehringer-ingelheim.ir
Transfer
WIPO DIR2015-0003
(Decision Date: July 28, 2015)
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll